Advancements in blood-based multi-cancer early detection screening platforms are on the horizon, bringing the latest advances in cancer screening technologies to patients and healthcare providers. Thought leader, Chetan Bettegowda, shares insights with the multidisciplinary team and addresses questions related to their experiences with MCED in real time.
Chetan Bettegowda, MD, PHD
Associate Professor, Department of Neurosurgery and Oncology
Johns Hopkins University School of Medicine
This project is sponsored by Exact Sciences.